Skip to main content

HIV PrEP

Featured Article

04/02/2025
Grace Taylor, MS, MA
A recent study shows rising pre-exposure prophylaxis (PrEP) utilization and declining costs as generic formulations replace branded versions in HIV prevention.
A recent study shows rising pre-exposure prophylaxis (PrEP) utilization and declining costs as generic formulations replace branded versions in HIV prevention.
A recent study shows rising...
04/02/2025
First Report Managed Care
News
07/24/2024
Grace Taylor, MS, MA
As HIV rates continue to rise among Latino gay and bisexual men, health policy advocates stress the need for more federal assistance for HIV treatment and prevention in this community.
As HIV rates continue to rise among Latino gay and bisexual men, health policy advocates stress the need for more federal assistance for HIV treatment and prevention in this community.
As HIV rates continue to rise...
07/24/2024
First Report Managed Care
News
07/15/2023
Maria Asimopoulos
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability,...
07/15/2023
First Report Managed Care
News
12/20/2022
Jolynn Tumolo
Researchers used clinic billing records in Washington, DC and Chicago to estimate the annual billable costs associated with the use of preexposure prophylaxis for HIV.
Researchers used clinic billing records in Washington, DC and Chicago to estimate the annual billable costs associated with the use of preexposure prophylaxis for HIV.
Researchers used clinic billing...
12/20/2022
First Report Managed Care
News
11/17/2022
Jolynn Tumolo
“Multiple participants suggested that initial counseling on PrEP should be offered universally to patients, regardless of sexual history or personal risk factors,” researchers advised.
“Multiple participants suggested that initial counseling on PrEP should be offered universally to patients, regardless of sexual history or personal risk factors,” researchers advised.
“Multiple participants suggested...
11/17/2022
First Report Managed Care
News
11/14/2022
Jolynn Tumolo
Investigators conducted a survey to determine how prevalent the use of pre- and post-exposure prophylaxis was among over 63,000 participants.
Investigators conducted a survey to determine how prevalent the use of pre- and post-exposure prophylaxis was among over 63,000 participants.
Investigators conducted a survey...
11/14/2022
First Report Managed Care
News
11/07/2022
Jolynn Tumolo
Among a variety of interventions, pre-exposure prophylaxis was the only method that showed consistent effectiveness in reducing the incidence of HIV, new findings show.
Among a variety of interventions, pre-exposure prophylaxis was the only method that showed consistent effectiveness in reducing the incidence of HIV, new findings show.
Among a variety of...
11/07/2022
First Report Managed Care
News
09/27/2022
Jolynn Tumolo
"Messages from health campaigns were perceived as most positive, and those from religious institutions as least positive," authors said.
"Messages from health campaigns were perceived as most positive, and those from religious institutions as least positive," authors said.
"Messages from health campaigns...
09/27/2022
First Report Managed Care
News
09/09/2022
Jolynn Tumolo
Study authors employed a strategy to monitor populations for HIV strains that are resistant to tenofovir and emtricitabine and ensure PrEP failure rates remain rare.
Study authors employed a strategy to monitor populations for HIV strains that are resistant to tenofovir and emtricitabine and ensure PrEP failure rates remain rare.
Study authors employed a...
09/09/2022
First Report Managed Care
News
09/02/2022
Jolynn Tumolo
High rates of psychological distress may represent an important barrier against HIV treatment adherence for Black men who have sex with men living in urban areas, researchers said.
High rates of psychological distress may represent an important barrier against HIV treatment adherence for Black men who have sex with men living in urban areas, researchers said.
High rates of psychological...
09/02/2022
First Report Managed Care
News
07/29/2022
Jolynn Tumolo
"While our findings showed some unanticipated relationships, they provide insight into how discrimination and stigma may influence PrEP use and disparities," researchers said.
"While our findings showed some unanticipated relationships, they provide insight into how discrimination and stigma may influence PrEP use and disparities," researchers said.
"While our findings showed some...
07/29/2022
First Report Managed Care

Newsfeed

News
07/24/2024
Grace Taylor, MS, MA
As HIV rates continue to rise among Latino gay and bisexual men, health policy advocates stress the need for more federal assistance for HIV treatment and prevention in this community.
As HIV rates continue to rise among Latino gay and bisexual men, health policy advocates stress the need for more federal assistance for HIV treatment and prevention in this community.
As HIV rates continue to rise...
07/24/2024
First Report Managed Care
News
07/15/2023
Maria Asimopoulos
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability,...
07/15/2023
First Report Managed Care
News
12/20/2022
Jolynn Tumolo
Researchers used clinic billing records in Washington, DC and Chicago to estimate the annual billable costs associated with the use of preexposure prophylaxis for HIV.
Researchers used clinic billing records in Washington, DC and Chicago to estimate the annual billable costs associated with the use of preexposure prophylaxis for HIV.
Researchers used clinic billing...
12/20/2022
First Report Managed Care
News
11/17/2022
Jolynn Tumolo
“Multiple participants suggested that initial counseling on PrEP should be offered universally to patients, regardless of sexual history or personal risk factors,” researchers advised.
“Multiple participants suggested that initial counseling on PrEP should be offered universally to patients, regardless of sexual history or personal risk factors,” researchers advised.
“Multiple participants suggested...
11/17/2022
First Report Managed Care
News
11/14/2022
Jolynn Tumolo
Investigators conducted a survey to determine how prevalent the use of pre- and post-exposure prophylaxis was among over 63,000 participants.
Investigators conducted a survey to determine how prevalent the use of pre- and post-exposure prophylaxis was among over 63,000 participants.
Investigators conducted a survey...
11/14/2022
First Report Managed Care
News
11/07/2022
Jolynn Tumolo
Among a variety of interventions, pre-exposure prophylaxis was the only method that showed consistent effectiveness in reducing the incidence of HIV, new findings show.
Among a variety of interventions, pre-exposure prophylaxis was the only method that showed consistent effectiveness in reducing the incidence of HIV, new findings show.
Among a variety of...
11/07/2022
First Report Managed Care
News
09/27/2022
Jolynn Tumolo
"Messages from health campaigns were perceived as most positive, and those from religious institutions as least positive," authors said.
"Messages from health campaigns were perceived as most positive, and those from religious institutions as least positive," authors said.
"Messages from health campaigns...
09/27/2022
First Report Managed Care
News
09/09/2022
Jolynn Tumolo
Study authors employed a strategy to monitor populations for HIV strains that are resistant to tenofovir and emtricitabine and ensure PrEP failure rates remain rare.
Study authors employed a strategy to monitor populations for HIV strains that are resistant to tenofovir and emtricitabine and ensure PrEP failure rates remain rare.
Study authors employed a...
09/09/2022
First Report Managed Care
News
09/02/2022
Jolynn Tumolo
High rates of psychological distress may represent an important barrier against HIV treatment adherence for Black men who have sex with men living in urban areas, researchers said.
High rates of psychological distress may represent an important barrier against HIV treatment adherence for Black men who have sex with men living in urban areas, researchers said.
High rates of psychological...
09/02/2022
First Report Managed Care
News
07/29/2022
Jolynn Tumolo
"While our findings showed some unanticipated relationships, they provide insight into how discrimination and stigma may influence PrEP use and disparities," researchers said.
"While our findings showed some unanticipated relationships, they provide insight into how discrimination and stigma may influence PrEP use and disparities," researchers said.
"While our findings showed some...
07/29/2022
First Report Managed Care
News
04/02/2026
Hannah Musick
A population health management approach using electronic health records and multidisciplinary care improved guideline-based treatment and care coordination in chronic kidney disease, highlighting a scalable strategy for value-based kidney...
A population health management approach using electronic health records and multidisciplinary care improved guideline-based treatment and care coordination in chronic kidney disease, highlighting a scalable strategy for value-based kidney...
A population health management...
04/02/2026
First Report Managed Care
News
03/31/2026
Grace Taylor, MS, MA
Glofitamab plus polatuzumab vedotin delivered high response rates and durable outcomes in heavily pretreated relapsed or refractory large B-cell lymphoma (R/R LBCL), including high-risk subgroups and prior chimeric antigen receptor (CAR)...
Glofitamab plus polatuzumab vedotin delivered high response rates and durable outcomes in heavily pretreated relapsed or refractory large B-cell lymphoma (R/R LBCL), including high-risk subgroups and prior chimeric antigen receptor (CAR)...
Glofitamab plus polatuzumab...
03/31/2026
First Report Managed Care
News
03/30/2026
Lisa Kuhns, PhD, MD
At 3 years, epcoritamab continues to deliver durable responses and manageable safety in heavily pretreated patients with relapsed or refractory large B-cell lymphoma (R/R LBCL), with sustained remissions seen in a substantial proportion of...
At 3 years, epcoritamab continues to deliver durable responses and manageable safety in heavily pretreated patients with relapsed or refractory large B-cell lymphoma (R/R LBCL), with sustained remissions seen in a substantial proportion of...
At 3 years, epcoritamab...
03/30/2026
First Report Managed Care
Behind the Bill
03/27/2026
Danielle Sposato
The White House recently announced the creation of a Task Force to Eliminate Fraud, designed to coordinate a national strategy addressing fraud, waste, and abuse across federal benefit programs, including health care.
The White House recently announced the creation of a Task Force to Eliminate Fraud, designed to coordinate a national strategy addressing fraud, waste, and abuse across federal benefit programs, including health care.
The White House recently...
03/27/2026
First Report Managed Care
News
03/26/2026
Lisa Kuhns, PhD, MD
Bispecific CD3/CD20 T-cell engagers deliver striking response rates with manageable safety in follicular lymphoma, positioning them as a potential game-changer in earlier lines of therapy.
Bispecific CD3/CD20 T-cell engagers deliver striking response rates with manageable safety in follicular lymphoma, positioning them as a potential game-changer in earlier lines of therapy.
Bispecific CD3/CD20 T-cell...
03/26/2026
First Report Managed Care
News
03/24/2026
Grace Taylor, MS, MA
The Centers for Medicare & Medicaid Services (CMS) has finalized a landmark rule to digitize health care claims attachments, aiming to cut costs, streamline workflows, and accelerate decisions for payers and providers.
The Centers for Medicare & Medicaid Services (CMS) has finalized a landmark rule to digitize health care claims attachments, aiming to cut costs, streamline workflows, and accelerate decisions for payers and providers.
The Centers for Medicare &...
03/24/2026
First Report Managed Care
News
03/24/2026
Lisa Kuhns, PhD, MD
Epcoritamab added to lenalidomide and rituximab markedly improves response rates and progression-free survival in relapsed or refractory follicular lymphoma, emerging as a potential new chemotherapy-free standard of care.
Epcoritamab added to lenalidomide and rituximab markedly improves response rates and progression-free survival in relapsed or refractory follicular lymphoma, emerging as a potential new chemotherapy-free standard of care.
Epcoritamab added to...
03/24/2026
First Report Managed Care
News
03/20/2026
Lisa Kuhns, PhD, MD
Machine learning models may help clinicians pinpoint which older patients with rheumatoid arthritis are most likely to fall off therapy—before it happens.
Machine learning models may help clinicians pinpoint which older patients with rheumatoid arthritis are most likely to fall off therapy—before it happens.
Machine learning models may help...
03/20/2026
First Report Managed Care
Behind the Bill
03/19/2026
Hannah Musick
A sweeping proposed Affordable Care Act (ACA) Marketplace rule for 2027 is drawing sharp pushback from states, setting up a high-stakes debate over coverage, affordability, and program integrity.
A sweeping proposed Affordable Care Act (ACA) Marketplace rule for 2027 is drawing sharp pushback from states, setting up a high-stakes debate over coverage, affordability, and program integrity.
A sweeping proposed Affordable...
03/19/2026
First Report Managed Care
News
03/18/2026
Hannah Musick
A systematic review of diffuse large B-cell lymphoma (DLBCL) registration trials found that while most primary outcomes are reported for older adults, key data on secondary endpoints, toxicity, and quality of life remain largely missing,...
A systematic review of diffuse large B-cell lymphoma (DLBCL) registration trials found that while most primary outcomes are reported for older adults, key data on secondary endpoints, toxicity, and quality of life remain largely missing,...
A systematic review of diffuse...
03/18/2026
First Report Managed Care

Insights

Headshot of Brian Mustanski, Northwestern University
Interview
04/14/2022
Maria Asimopoulos
Brian Mustanski, PhD, professor of medical social sciences, Northwestern University, shares factors influencing whether patients reinitiate preexposure prophylaxis for HIV after discontinuation.
Brian Mustanski, PhD, professor of medical social sciences, Northwestern University, shares factors influencing whether patients reinitiate preexposure prophylaxis for HIV after discontinuation.
Brian Mustanski, PhD, professor...
04/14/2022
First Report Managed Care
Chris Beyrer
Podcasts
06/30/2021
Julie Gould
Chris Beyrer, MD, infectious disease epidemiologist and professor at Johns Hopkins Bloomberg School of Public Health, breaks down current rates of HIV across the United States as well as the challenges linked with controlling this...
Chris Beyrer, MD, infectious disease epidemiologist and professor at Johns Hopkins Bloomberg School of Public Health, breaks down current rates of HIV across the United States as well as the challenges linked with controlling this...
Chris Beyrer, MD, infectious...
06/30/2021
First Report Managed Care
Podcasts
01/25/2021
Ed Pezalla, MD, CEO, Enlightenment Bioconsult LLC, speaks about the barriers to preventive HIV care, pinpoints how payers can reach at-risk populations, and reviews the US Preventive Services Task Force’s measures requiring health plans to...
Ed Pezalla, MD, CEO, Enlightenment Bioconsult LLC, speaks about the barriers to preventive HIV care, pinpoints how payers can reach at-risk populations, and reviews the US Preventive Services Task Force’s measures requiring health plans to...
Ed Pezalla, MD, CEO,...
01/25/2021
First Report Managed Care
Videos
09/23/2020
Max Lataillade, DO, head of global research strategy, ViiV Healthcare, discusses the findings of the BRIGHTE study that demonstrated a significant decrease in HIV-1 RNA levels among patients treated with fostemsavir, a first-in-class...
Max Lataillade, DO, head of global research strategy, ViiV Healthcare, discusses the findings of the BRIGHTE study that demonstrated a significant decrease in HIV-1 RNA levels among patients treated with fostemsavir, a first-in-class...
Max Lataillade, DO, head of...
09/23/2020
First Report Managed Care